Hougen Elizabeth L - Jun 24, 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Director
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Jun 24, 2025
Transactions value $
$0
Form type
4
Date filed
6/26/2025, 04:30 PM
Previous filing
Feb 3, 2025
Next filing
Oct 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HOUGEN ELIZABETH L Director C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Neha Krishnamohan, Attorney-in-Fact 2025-06-26 0001074773

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTV Director Stock Option (Right to Buy) Award $0 +13.8K $0.00 13.8K Jun 24, 2025 Common Stock 13.8K $1.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in full on the earlier of June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting.